Mitochondrial-Encoded MOTS-C Prevents Pancreatic Islet Destruction in Autoimmune Diabetes

Type 1 diabetes (T1D) patients had a lower serum MOTS-c level than did healthy controls. Furthermore, MOTS-c reduced T cell activation by alleviating T cells from the glycolytic stress in T1D patients, suggesting therapeutic potential.